Get startedLog in
    Picture of BLS Pharmaceuticals logo

    BLS — BLS Pharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    All News

    Australia's BLS Pharmaceuticals gains on agreement to commercialise Trexapharm

    Picture of BLS Pharmaceuticals logoBLS Pharmaceuticals
    22/07/2026 06:56
    BUZZ-Australia's BLS Pharmaceuticals gains on agreement to commercialise Trexapharm
    ** Shares of BLS Pharmaceuticals BLS.AX rise 3.6% to A$0.87, headed for their best session since July 13, if trends hold
    ** Consumer health and pharma co signs non-binding head of agreement with Australia based biopharmaceutical co Trexapharm
    ** Agreement is for the Australian commercialisation of TREXAVIVE, BLS's patented neurotherapy for treatment-resistent depression
    ** Stock more than doubles YTD, including session's moves


     (Reporting by Shravya Marakini in Bengaluru)
     ((Shravya.Marakini@thomsonreuters.com;))

    Recent news on BLS Pharmaceuticals

    See all news